-
September 20, 2016PREVIEW
Abaloparatide, an investigational peptide that selectively activates the parathyroid hormone (PTH)–type 1 receptor, reduced the risk of new vertebral and nonvertebral fractures and increased bone...
-
September 12, 2016PREVIEW
Biosimilar versions of tumor necrosis factor–alpha (TNF-α) inhibitors may be viable substitutions for their biologic reference drugs, with data supporting similar pharmacokinetic parameters,...
-
August 30, 2016PREVIEW
The European League Against Rheumatism (EULAR) released points to consider when managing pregnant and lactating women with a rheumatic disease that focus on preplanning, use of specific...
-
August 23, 2016PREVIEW
Long-term use of alendronate, including more than 10 years of continuous use, was not associated with an increased risk of subtrochanteric femur and femoral shaft (ST/FS) fractures and was...
-
April 26, 2016PREVIEW
Tocilizumab (Actemra—Genentech) monotherapy in glucocorticoid-free patients with recent-onset polymyalgia rheumatica was found to be effective, according to the results of a small, open-label...
Pages
